Renoprotective effect of Erdosteine in rats against gentamicin nephrotoxicity: a comparison of 99mTc-DMSA uptake with biochemical studies
Tóm tắt
Erdosteine is a mucolytic agent having antioxidant properties through its active metabolites in acute injuries induced by pharmacological drugs. This study was designed to investigate the renoprotective potential of Erdosteine against gentamicin (GM)-induced renal dysfunction by using Technetium-99 m dimercaptosuccinic acid (Tc-99 m DMSA) uptake and scintigraphy in rats. For this purpose, male Wistar rats were randomly allotted into one of the four experimental groups: Control, Erdosteine, GM, and GM + Erdosteine groups. GM and GM + Erdosteine groups received 100 mg/kg GM intramuscularly for 6 days. In addition, Erdosteine and GM + Erdosteine groups received 50 mg/kg Erdosteine orally for 6 days. Renal function tests were assessed by serum blood urea nitrogen (BUN), creatinine levels, as well as scintigraphic and tissue radioactivity measurements with Tc-99 m DMSA. Renal oxidative damage was determined by renal malondialdehyde (MDA) levels, by antioxidant enzyme activities; superoxide dismutase (SOD) and catalase (CAT) and activities of oxidant enzymes; xanthine oxidase (XO) and myeloperoxidase (MPO). GM administration resulted in marked renal lipid peroxidation, increased XO and MPO activities and decreased antioxidant enzyme activities. GM + Erdosteine group significantly had lower MDA levels, higher SOD and CAT activities and lower XO and MPO activities, when compared to GM. Also GM + Erdosteine had lower levels of serum BUN, creatinine and higher renal tissue Tc-99 m DMSA uptake and radioactivity with respect to GM. In conclusion, our results supported a protective role of Erdosteine in nephrotoxicity associated with GM treatment.
Tài liệu tham khảo
Ho JL, Barza M (1987) Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection. Antimicrob Agents Chemother 31:485–491
Lerner SA, Schmitt BA, Seligsohn R, Matz GJ (1986) Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med 80:98–104
Rodriguez-Barbero A, Lopez-Novoa JM, Arevalo M (1997) Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats. Exp Nephrol 5:47–54
Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di PR, Britti D, De SA, Pierpaoli S, Caputi A, Masini E et al (2002) A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol 450:67–76
Halliwell B, Gutteridge JM (1984) Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1:1396–1397
Halliwell B (1997) Antioxidants and human disease: a general introduction. Nutr Rev 55:S44–S49
Dechant KL, Noble S (1996) Erdosteine. Drugs 52:875–881
Gurel A, Armutcu F, Cihan A, Numanoglu KV, Unalacak M (2004) Erdosteine improves oxidative damage in a rat model of renal ischemia-reperfusion injury. Eur Surg Res 36:206–209
Piepsz A (2002) Radionuclide studies in paediatric nephro-urology. Eur J Radiol 43:146–153
Yamada M (1991) Assessment of 99mTc-DMSA renography and uptake compared with creatinine clearance in rats with drug-induced nephrotoxicity—I. Gentamicin-induced nephrotoxicity. Kaku Igaku 28:339–345
Yamada M (1991) Assessment of 99mTc-DMSA renography and uptake compared with creatinine clearance in rats with drug-induced nephrotoxicity—II. Cisplatin-induced nephrotoxicity. Kaku Igaku 28:347–354
Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431
Prajda N, Weber G (1975) Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 59:245–249
Aebi (1974) Catalase. New York and London Academic Press
Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Ekor M, Farombi EO, Emerole GO (2006) Modulation of gentamicin-induced renal dysfunction and injury by the phenolic extract of soybean (Glycine max). Fundam Clin Pharmacol 20:263–271
Farombi EO, Ekor M (2006) Curcumin attenuates gentamicin-induced renal oxidative damage in rats. Food Chem Toxicol 44:1443–1448
Inglesi M, Nicola M, Fregnan GB, Bradamante S, Pagani G (1994) Synthesis and free radical scavenging properties of the enantiomers of erdosteine. Farmaco 40:703–708
Miyake K, Kaise T, Hosoe H, Akuta K, Manabe H, Ohmori K (1999) The effect of erdosteine and its active metabolite on reactive oxygen species production by inflammatory cells. Inflamm Res 48:205–209
Hayashi K, Hosoe H, Kaise T, Ohmori K (2000) Protective effect of erdosteine against hypochlorous acid-induced acute lung injury and lipopolysaccharide-induced neutrophilic lung inflammation in mice. J Pharm Pharmacol 52:1411–1416
Kavutcu M., Canbolat O., Ozturk S., Olcay E., Ulutepe S., Ekinci C., Gokhun I.H., Durak I (1996). Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: effects of vitamins E and C. Nephron 72: 269–274
Rajeswari A, Varalakshmi P (2006) Low molecular weight heparin protection against oxalate-induced oxidative renal insult. Clin Chim Acta 370:108–114
Fadillioglu E, Yilmaz HR, Erdogan H, Sogut S (2003) The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine. Toxicology 191:153–158
Parlakpinar H, Tasdemir S, Polat A, Bay-Karabulut A, Vardi N, Ucar M, Acet A (2005) Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. Toxicology 207:169–177
Lora-Michiels M, Anzola K, Amaya G, Solano M (2001) Quantitative and qualitative scintigraphic measurement of renal function in dogs exposed to toxic doses of Gentamicin. Vet Radiol Ultrasound 42:553–561
Bingham JB, Maisey MN, Joyce MR, Saxton HM (1978) Use of 99Tcm-DMSA as a static renal imaging agent. Contrib Nephrol 11:95–99